Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Inventory (2016 - 2023)

Perspective Therapeutics' Inventory history spans 13 years, with the latest figure at $1.0 million for Q3 2023.

  • For Q3 2023, Inventory fell 34.77% year-over-year to $1.0 million; the TTM value through Sep 2023 reached $1.0 million, down 34.77%, while the annual FY2022 figure was $1.4 million, N/A changed from the prior year.
  • Inventory for Q3 2023 was $1.0 million at Perspective Therapeutics, down from $1.1 million in the prior quarter.
  • Across five years, Inventory topped out at $1.6 million in Q3 2022 and bottomed at $501000.0 in Q3 2019.
  • The 5-year median for Inventory is $980000.0 (2021), against an average of $921842.1.
  • The largest annual shift saw Inventory surged 65.37% in 2021 before it plummeted 34.77% in 2023.
  • A 5-year view of Inventory shows it stood at $545000.0 in 2019, then grew by 22.02% to $665000.0 in 2020, then soared by 60.6% to $1.1 million in 2021, then surged by 31.93% to $1.4 million in 2022, then fell by 28.11% to $1.0 million in 2023.
  • Per Business Quant, the three most recent readings for CATX's Inventory are $1.0 million (Q3 2023), $1.1 million (Q2 2023), and $1.4 million (Q1 2023).